Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNCOVERED: Davita | History Defined

Are Wall Street Analysts Bullish on DaVita Stock?

Though DaVita has outpaced the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

Barchart

What You Need To Know Ahead of DaVita’s Earnings Release

DaVita is entering earnings with strong momentum as investors look for another quarter of solid execution.

Barchart

Akebia Therapeutics Sees Vafseo Uptake Rising as Access and Pipeline Milestones Near

Akebia Therapeutics (NASDAQ:AKBA) outlined its commercial priorities for Vafseo, the expected evolution of reimbursement after the TDAPA period and several renal-disease pipeline programs during a fireside chat at the Jefferies 2026 Global Healthcare Conference. Erik, Akebia’s chief financial offic

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

What Are Wall Street Analysts' Target Price for DaVita Stock?

DaVita has outpaced the broader market over the past year, with Wall Street analysts maintaining a cautiously optimistic outlook on the stock’s long-term prospects.

Barchart

What to Expect From DaVita's Next Quarterly Earnings Report

DaVita is set to announce its first-quarter results in May, with analysts forecasting a double-digit increase in the company’s bottom-line figure.

Barchart

How Berkshire Hathaway Performed During Buffett's Final Quarter

Buffett’s final quarter saw a 25% drop in net income, but his final portfolio moves—including increased positions in Chubb and Chevron—have proven prescient.

MarketBeat

Berkshire’s New CEO Just Offloaded DaVita Stocks: Should You Sell Yours Too?

For the first time since 1965, Berkshire Hathaway has made a major trade under the direction of someone other than former CEO Warren Buffett. The conglomerate recently sold roughly 1.65 million shares...

GOBankingRates

Read news from The Economist, FT, and more,
with one subscription

DaVita Stock: Is Wall Street Bullish or Bearish?

Are Wall Street analysts bullish or bearish on DaVita’s stock after its fourth-quarter earnings?

Barchart

Hedge Funds Are Shorting This Classic Warren Buffett Stock. Should You Sell Shares Now?

Hedge funds are betting against DaVita, but low valuations and steady cash flow suggest this Buffett stock may be bruised, not broken.

Barchart

Here's What to Expect From DaVita's Next Earnings Report

DaVita is set to announce its fourth-quarter results soon, with analysts forecasting a double-digit increase in the company’s bottom-line figure.

Barchart

Behind Berkshire’s Curtain: Is Greg Abel Preparing to Cut Davita Loose?

Davita hit its 23rd new 52-week low on Tuesday. Its stock is now within a few dollars of trading in double digits. That’s not a good thing, given that its share price was nearly $180 a year ago.

Barchart

Is DaVita Stock Underperforming the Dow?

As DaVita has underperformed relative to the Dow over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Barchart

The Biggest Cybersecurity Threats to Watch Out For In 2026

This year, more than eight ransomware attacks occurred, targeting major companies such as Ingram, Microsoft, Volvo, and DaVita. In 2026, with the aid of AI and AI Agents, these attacks will likely see a spike like never before.

inkl

DaVita Stock: Analyst Estimates & Ratings

DaVita has considerably underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times UK

Buffett's Berkshire Hathaway Sells 401K DaVita Shares Two Days Before Q3 Earnings Decline

Warren Buffett's Berkshire Hathaway sold over 401,000 shares of healthcare firm DaVita days before its stock price fell following lower Q3 earnings.

Barchart

Is DaVita Stock Underperforming the Nasdaq?

As DaVita has considerably underperformed the Nasdaq recently, analysts remain cautious about the stock’s prospects.

Benzinga

What's Going With Dialysis Firm DaVita Stock On Friday?

The U.S. health department's website reported that a ransomware attack between March and April against dialysis provider DaVita Inc. (NYSE:DVA) exposed the personal data of 2.7 million people.

TechRadar

Huge healthcare breach sees nearly a million patients hit following DaVita ransomware attack - make sure you're safe

Healthcare giant DaVita hit by Interlock attack, and warns patients to remain vigilant.

Get all your
news in one place.

100's of premium titles.
One news app.

Tom’s Guide

Over 900,000 hit in massive healthcare data breach — names, addresses and Social Security numbers exposed online

DaVita fell victim to a cyberattack back in March of this year during which time hackers gained unauthorized access to its servers.

Benzinga

Warren Buffett's Berkshire Hathaway Offloads $230 Million In DaVita Stock Ahead Of Q2 Earnings

Warren Buffett’s Berkshire Hathaway Inc. (NYSE:BRK) (NYSE:BRK) has sold off a significant portion of its holdings in DaVita Inc. (NYSE:DVA), a leading dialysis service provider, just before the latter’s Q2 earnings report.

GOBankingRates

7 Stocks Warren Buffet Has Sold So Far in 2025

If Buffett is unloading some stocks, it pays to take a closer look at their fundamentals. Here's a quick look at the stocks that he's been selling in 2025.

Barchart

DaVita’s Quarterly Earnings Preview: What You Need to Know

DaVita is expected to unveil its second-quarter results in the upcoming month, and analysts expect a single-digit rise in its profitability.

Barchart

Is DaVita Stock Underperforming the S&P 500?

DaVita’s performance over the past year has fallen short of the broader S&P 500 Index, prompting a neutral outlook from analysts regarding its future prospects.

Fortune

DaVita CEO Javier Rodriguez: The Trump administration is 'very aggressive in trying to change the trajectory of health care'

Also: All the news and watercooler chat from Fortune.

International Business Times UK

Warren Buffett Sells $168M in Davita Shares One Day Before Dialysis Provider Hit by Lawsuit

Berkshire Hathaway chair Warren Buffett sold over a million shares of DaVita worth £126.23 million on 8th May, a day before the dialysis service provider was sued by an employee benefits plan.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.